Home
Home Page
Recent Posts
Top Active Boards
Popular Posts
Biotech Tweets
Market Tweets
Energy Industry Tweets
Official IV Sponsor Page
My Content
My Boards
My Feed
My Library
My Links
Boards Search
Groups Directory
My Network
My Favorite Posters
My Private Message Groups
My Blocked Sender List
Member Directory
Account
Email & Password
Subscription/Membership
All Account Details
My Profile
My Device Info
Sign Up
Settings
My Site Settings
My Notification Settings
BOARDS
Sign In for Filters
|
BOARDS
Become a Member
|
Sign In
Advertise With Us
Board Stats
:
28 members / 115 guests [20]
AbbVie Inc.
Watch this video to learn more about IV Lite
The Perfect Plan for Lurkers
Board
Links
(more...)
Y!
AbbVie web page
Seeking alpha abbv
#ABBV @ Stocktwits
$ABBV stream @ Twitter
@abbvie (Company Twitter Account)
ABBV Facebook Page
ABBV @ LinkedIn
ABBV @ Instagram
ABBV YouTube Channel
ABBV @ BioPharmaCatalyst.com
ABBV / Message Board
BOARD
GROUPS
Loading...
Written By
On Topic Only
--
All Messages
Hide Replies
Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
Go to Msg #
MSG #
SUBJECT
TYPE
AUTHOR
SENTIMENT
RECS
DATE POSTED
631
AbbVie's Q1 Good News That Investors Could Be Missing
GN
jerrykrause
2
5/2/2022 5:34:35 PM
630
AbbVie (ABBV) Q1 Earnings Top, Competition Rises for Imbruvica
GN
jerrykrause
1
5/2/2022 5:19:07 PM
629
AbbVie Unites with Plexium to Leverage Protein Degraders Against Neurological Diseases
GN
jerrykrause
0
4/30/2022 12:39:04 PM
628
AbbVie Shares Drop Amid Missed Sales Expectations for Key Drugs
GN
jerrykrause
0
4/29/2022 10:23:20 PM
627
AbbVie terminates collaboration with BioArctic on alpha-synuclein portfolio
GN
jerrykrause
0
4/23/2022 12:08:54 PM
626
AbbVie preps filings for lymphoma bispecific licensed from Genmab
GN
jerrykrause
0
4/16/2022 12:06:22 PM
625
AbbVie and Genmab Announce Topline Results for Epcoritamab (DuoBody®-CD3xCD20) from Phase 1/2 Trial in Patients with Relapsed/Refractory Large B-cell Lymphoma (LBCL)
GN
jerrykrause
1
4/16/2022 12:05:32 PM
624
AbbVie reports positive data from Phase II myelofibrosis therapy trial
GN
jerrykrause
1
4/14/2022 4:59:47 PM
623
AbbVie Stock Breaks Its Stride As Key Executive Departs For Flagship
GN
jerrykrause
0
4/13/2022 5:57:27 PM
622
Market makers
GN
andrew0329
0
4/12/2022 10:01:48 AM
Go to Msg #
About Us
•
Contact Us
•
Follow Us on Twitter
•
Members Directory
•
Help Center
•
Advertise
•
Official IV Sponsor Page
Become a Patron
© 2003-2022 Investorvillage.com. All rights reserved.
User Agreement
Financial Market Data provided by
.
Loading...